BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 527267)

  • 1. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
    Tosner J; Fixa B
    Cas Lek Cesk; 1984 Mar; 123(12):354-7. PubMed ID: 6085556
    [No Abstract]   [Full Text] [Related]  

  • 5. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of leucocyte migration in women with ovarian carcinoma, and its dependence on the quantity of lymphocytes forming E-rosettes (author's transl)].
    Tosner J; Vejbora O; Fixa B
    Cas Lek Cesk; 1981 Sep; 120(38):1150-4. PubMed ID: 7273087
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of leukocyte migration in agar by soluble extract from a human ovarian carcinoma cell line.
    Sekiguchi M; Shibusawa M; Asanuma K; Kaku R; Wagatsuma T; Kobayashi H; Fujii G
    Jpn J Exp Med; 1982 Jun; 52(3):119-24. PubMed ID: 7131857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte migration inhibition test in patients with gynaecologic malignancy.
    Tosner J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(4):415-89. PubMed ID: 6978511
    [No Abstract]   [Full Text] [Related]  

  • 9. A sequential study of humoral factors in ovarian neoplasms.
    Gupta SC; Agarwal J; Singh PA; Mehdiratta NK; Keswani NK
    Indian J Pathol Microbiol; 1994 Jul; 37(3):319-26. PubMed ID: 7814065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formalinized tumour cells in the leucocyte migration inhibition test.
    Ross CE; Cochran AJ; Hoyle DE; Grant RM; Mackie RM
    Clin Exp Immunol; 1975 Oct; 22(1):126-32. PubMed ID: 1212813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of ovarian carcinoma tissue culture in the leukocyte migration inhibition test].
    Tosner J; Fixa B; Jirkalová V; Donát J
    Cas Lek Cesk; 1987 Apr; 126(14):439-41. PubMed ID: 3581139
    [No Abstract]   [Full Text] [Related]  

  • 12. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the concentration and origin of antigens on leukocyte migration in women with malignant gynecologic tumors].
    Tosner J; Fixa B
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1980; 23(2):121-7. PubMed ID: 6969923
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigenicity of a fetal extract in the leucocyte migration-inhibition test.
    Uehara Y; Kojima O; Kitagawa N; Oh A; Nishioka B; Fujita Y; Majima S
    Oncodev Biol Med; 1983; 4(5):335-41. PubMed ID: 6856483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of leucocyte migration by antigens from human colon and E. coli O 14 in patients with ulcerative colitis.
    Fixa B; Komárová O; Skaunic V; Nerad M; Kojecký Z; Benỳŝek L
    Scand J Gastroenterol; 1975; 10(5):491-3. PubMed ID: 1098133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and late treatment results in ovarian cancer].
    Stambrovskaia AA; Siparov IN
    Vopr Onkol; 1982; 28(6):77-81. PubMed ID: 6211834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of leucocyte migration inhibition test in coeliac disease. A reassessment using different gluten subfractions.
    Corazza GR; Rawcliffe PM; Frisoni M; Sarchielli P; Londei M; Campieri M; Lazzari R; Gasbarrini G
    Clin Exp Immunol; 1985 Apr; 60(1):117-22. PubMed ID: 4006297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucocyte migration inhibition response to tissue antigens in asymptomatic individuals infected with Trypanosoma cruzi.
    Peralta JM; Gill K; Cordeiro Lima MF; Coura JR
    Clin Exp Immunol; 1981 Sep; 45(3):621-6. PubMed ID: 6802533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitization study of oncological patients to bacterial allergens with the aid of the leukocyte migration inhibition reaction].
    Kochetkova VA; Znamenskaia IN
    Vopr Onkol; 1981; 27(2):39-43. PubMed ID: 7210594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.